GSA Capital Partners LLP Purchases 6,211 Shares of Humana Inc (HUM)

GSA Capital Partners LLP lifted its position in shares of Humana Inc (NYSE:HUM) by 159.3% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 10,111 shares of the insurance provider’s stock after acquiring an additional 6,211 shares during the quarter. GSA Capital Partners LLP’s holdings in Humana were worth $2,463,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the company. WFG Advisors LP raised its position in shares of Humana by 4.5% during the second quarter. WFG Advisors LP now owns 469 shares of the insurance provider’s stock worth $113,000 after acquiring an additional 20 shares during the last quarter. Cadence Capital Management LLC raised its position in shares of Humana by 0.4% during the second quarter. Cadence Capital Management LLC now owns 5,682 shares of the insurance provider’s stock worth $1,367,000 after acquiring an additional 22 shares during the last quarter. Financial Advisors Network Inc. raised its position in shares of Humana by 3.4% during the second quarter. Financial Advisors Network Inc. now owns 1,413 shares of the insurance provider’s stock worth $340,000 after acquiring an additional 46 shares during the last quarter. Nordea Investment Management AB raised its position in shares of Humana by 1.0% during the second quarter. Nordea Investment Management AB now owns 7,338 shares of the insurance provider’s stock worth $1,766,000 after acquiring an additional 74 shares during the last quarter. Finally, Cambridge Investment Research Advisors Inc. raised its position in shares of Humana by 4.6% during the second quarter. Cambridge Investment Research Advisors Inc. now owns 2,095 shares of the insurance provider’s stock worth $504,000 after acquiring an additional 92 shares during the last quarter. Institutional investors own 94.19% of the company’s stock.

Humana Inc (NYSE HUM) traded down $5.63 during trading hours on Friday, reaching $250.61. The company’s stock had a trading volume of 1,353,500 shares, compared to its average volume of 1,375,474. Humana Inc has a 1 year low of $186.25 and a 1 year high of $264.56. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 0.35. The firm has a market capitalization of $36,606.47, a PE ratio of 21.86, a price-to-earnings-growth ratio of 1.76 and a beta of 0.88.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, November 8th. The insurance provider reported $3.39 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.27 by $0.12. Humana had a return on equity of 15.99% and a net margin of 3.49%. The firm had revenue of $13.28 billion during the quarter, compared to analysts’ expectations of $13.41 billion. During the same period in the previous year, the firm earned $3.18 earnings per share. The company’s revenue was down 3.0% on a year-over-year basis. equities analysts expect that Humana Inc will post 11.63 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, December 29th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $1.60 dividend on an annualized basis and a yield of 0.64%. Humana’s payout ratio is 12.59%.

A number of equities research analysts have recently weighed in on the company. Credit Suisse Group assumed coverage on Humana in a research report on Thursday, November 2nd. They set a “neutral” rating and a $256.00 target price for the company. Zacks Investment Research downgraded Humana from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 17th. BidaskClub downgraded Humana from a “hold” rating to a “sell” rating in a report on Thursday, August 17th. Morgan Stanley dropped their price objective on Humana from $276.00 to $270.00 and set an “overweight” rating for the company in a report on Thursday, November 9th. Finally, Cowen reiterated a “buy” rating and issued a $285.00 price objective on shares of Humana in a report on Wednesday. Twelve analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $256.30.

ILLEGAL ACTIVITY WARNING: This news story was reported by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this news story on another publication, it was illegally copied and republished in violation of United States and international trademark and copyright laws. The legal version of this news story can be viewed at https://stocknewstimes.com/2017/12/15/gsa-capital-partners-llp-purchases-6211-shares-of-humana-inc-hum.html.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply